PHS
INVA icon

PFM Health Sciences’s Innoviva INVA Stock Holding History

PFM Health Sciences’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-133,897
Closed -$1.41M – 94
2016
Q2 		$1.41M Sell
133,897
-1,352,317
-91% -$16M 0.04% 77
2016
Q1 		$18.7M Sell
1,486,214
-825,467
-36% -$9.06M 0.58% 50
2015
Q4 		$24.4M Buy
+2,311,681
New +$21.3M 0.74% 43

Other funds holding INVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
LM
Litespeed Management New York $48.2M AUM 9.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PFM Health Sciences's INVA Position: Q3 2016 in Review

PFM Health Sciences sold out of Innoviva (INVA) in Q3 2016, closing a stake of 133,897 shares — an estimated $1.41M sold.

PFM Health Sciences first reported a position in INVA in Q4 2015 and held it in 3 quarters. The position peaked at $24.4M in Q4 2015. 140 funds tracked by Wall St. Rank hold INVA as of Q3 2016.

  • PFM Health Sciences reported no remaining Innoviva position as of Q3 2016 after selling out during the quarter.
  • PFM Health Sciences sold 133,897 Innoviva shares in Q3 2016, an estimated $1.41M.
  • PFM Health Sciences first reported a position in Innoviva in Q4 2015 and held it in 3 quarters.
  • PFM Health Sciences's Innoviva position peaked at $24.4M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Innoviva as of Q3 2016.

Based on PFM Health Sciences's 13F filing for Q3 2016, filed 14 Nov 2016.